C

CorMedix
D

CRMD

11.330
USD
0.29
(2.63%)
مغلق
حجم التداول
53,884
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
884,405,139
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.